Who Exports Atazanavir from India — 17 Suppliers Behind a $71.2M Market
India's atazanavir export market is supplied by 17 active exporters who collectively shipped $71.2M across 473 shipments. MYLAN LABORATORIES LIMITED leads with a 62.9% market share, followed by EMCURE PHARMACEUTICALS LIMITED and HETERO LABS LIMITED. The top 5 suppliers together control 99.2% of total export value, reflecting a concentrated market structure.
Top Atazanavir Exporters from India — Ranked by Export Value
MYLAN LABORATORIES LIMITED is the leading atazanavir exporter from India, holding a 62.9% share of the $71.2M market across 473 shipments from 17 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, EMCURE PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, EMCURE PHARMACEUTICALS LTD, CIPLA LIMITED — collectively control 99.2% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (62.9%), EMCURE PHARMACEUTICALS LIMITED (23.1%), HETERO LABS LIMITED (5.0%), EMCURE PHARMACEUTICALS LTD (4.9%), CIPLA LIMITED (3.3%).
Top Atazanavir Exporters from India
Ranked by export value · 17 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED ANZAVIR-R TABLETSATAZANAVIR 300MG + RITONAVIR 100MG) TABLANZAVIR-R(ATAZANAVIR 300MG + RITONAVIR 1 | $44.8M | 55 | 62.9% |
| 2 | EMCURE PHARMACEUTICALS LIMITED ANZAVIR-R TABLETSATAZANAVIR 300MG + RITONAVIR 100MG) TABLANZAVIR-R TABLETS - NO CARTON | $16.4M | 48 | 23.1% |
| 3 | HETERO LABS LIMITED VIRATAZ RITONAVIR 100 MG + ATAZANAVIR SUVIRATAZ RITONAVIR+ATAZANAVIR SULFATE TABLETVIRATAZ NOS | $3.6M | 5 | 5.0% |
| 4 | EMCURE PHARMACEUTICALS LTD ANZAVIR-R TABLETSATAZANAVIR 300MG + RITONAVIR 100MG) TABLANZAVIR-R TABLETS - NO CARTON | $3.5M | 6 | 4.9% |
| 5 | CIPLA LIMITED TARITO 300/100 TABLET | $2.4M | 1 | 3.3% |
| 6 | MACLEODS PHARMACEUTICALS LIMITED | $369.0K | 1 | 0.5% |
| 7 | S D PHARMACEUTICALS ANZAVIR-R TABLETSATAZANAVIR 300MG + RITONAVIR 100MG) TABLANZAVIR-R(ATAZANAVIR 300MG + RITONAVIR 1 | $32.9K | 1 | 0.0% |
| 8 | D VIJAY PHARMA PRIVATE LIMITED ANZAVIR-R TABLETSATAZANAVIR 300MG + RITONAVIR 100MG) TABLANZAVIR-R(ATAZANAVIR 300MG + RITONAVIR 1 | $3.9K | 2 | 0.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Atazanavir exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| CIPLA LIMITED | Warning Letter (February | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Verna, Goa facility. |
| EMCURE PHARMACEUTICALS LIMITED | Warning Letter (August 20 | Unknown | Unknown | Not verified | FDA issued a warning letter for repeat CGMP violations at the Hinjawadi, Pune fa |
| MYLAN LABORATORIES LIMITED | Warning Letter (April 201 | Unknown | Unknown | Not verified | FDA issued a warning letter citing data integrity lapses at the Nashik FDF facil |
| HETERO LABS LIMITED | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found; other certification statuses unknown. |
| MACLEODS PHARMACEUTICALS LIMITED | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found; other certification statuses unknown. |
| S D PHARMACEUTICALS | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found; other certification statuses unknown. |
| D VIJAY PHARMA PRIVATE LIMITED | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found; other certification statuses unknown. |
TransData Nexus reviewed the regulatory standing of 7 leading Atazanavir exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Atazanavir sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma Capital of India," is a pivotal center for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production, earning it the title of the "Bulk Drug Capital of India." This prominence is supported by the presence of over 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Genome Valley, a premier biotech cluster, further enhances Hyderabad's status as a hub for pharmaceutical innovation and production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations. Gujarat leads India with a 33% share in drug manufacturing and a 28% share in drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's pharmaceutical industry has grown substantially, with numerous companies operating in and around Vadodara, contributing to its reputation as a major pharmaceutical hub.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. The region hosts several pharmaceutical companies, leveraging its strategic location and well-developed infrastructure to streamline export operations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing to its rapid industrial growth.
5Sourcing Recommendations
- Diversify Supplier Base: Given the high concentration of Atazanavir exports among a few suppliers, consider engaging with multiple manufacturers to mitigate supply chain risks.
- Evaluate Manufacturing Clusters: Assess the capabilities of pharmaceutical clusters in Hyderabad, Ahmedabad-Vadodara, and Mumbai-Thane-Raigad to identify potential suppliers with robust production and export infrastructures.
- Leverage Export Gateways: Utilize the strategic location of the Mumbai-Thane-Raigad region to facilitate efficient export logistics and reduce lead times.
- Monitor Regulatory Compliance: Ensure that selected suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Atazanavir exporters from India
Emcure Pharmaceuticals Limited — Emcure partners with Gilead for generic Lenacapavir production
Emcure Pharmaceuticals entered into a non-exclusive, royalty-free voluntary licensing agreement with Gilead Sciences to manufacture and distribute generic versions of Lenacapavir, an HIV drug, in 120 resource-limited countries. - IMPACT: This collaboration may enhance Emcure's capabilities in antiretroviral production, potentially influencing its Atazanavir export operations.
Impact: This collaboration may enhance Emcure's capabilities in antiretroviral production, potentially influencing its Atazanavir export operations.
Common Questions — Atazanavir Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which atazanavir supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 226 recorded shipments worth $44.8M. EMCURE PHARMACEUTICALS LIMITED (159 shipments) and HETERO LABS LIMITED (43 shipments) are also established high-volume exporters.
Q How many atazanavir manufacturers are there in India?
India has 17 active atazanavir exporters with a combined export market of $71.2M across 473 shipments to 88 countries. The top 5 suppliers hold 99.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for atazanavir from India?
Average FOB unit price: $4.67 per unit, ranging from $0.00 to $34.69. Average shipment value: $150.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 17 verified Indian exporters of Atazanavir ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 473 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 88 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
473 Verified Shipments
17 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists